CL:CA Cresco Labs Inc

CAD 2.78 -0.27 -8.852459
Icon

Cresco Labs Inc (CL:CA) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - Specialty & Generic | CNSX
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

CAD 2.78

-0.27 (-8.85)%

CAD 0.94B

0.48M

CAD 2.98(+7.31%)

CAD 7.50 (+169.78%)

Icon

CL:CA

Cresco Labs Inc (CAD)
COMMON STOCK | CNSX
CAD 2.78
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

CAD 0.94B

CAD 7.50 (+169.78%)

CAD 2.78

Cresco Labs Inc (CL:CA) Stock Forecast

CAD 2.98
(+7.31%)

Based on the Cresco Labs Inc stock forecast from 3 analysts, the average analyst target price for Cresco Labs Inc is CAD 2.98 over the next 12 months. Cresco Labs Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Cresco Labs Inc is Bearish, which is based on 2 positive signals and 7 negative signals. At the last closing, Cresco Labs Inc’s stock price was CAD 2.78. Cresco Labs Inc’s stock price has changed by -6.40% over the past week, +16.32% over the past month and +28.70% over the last year.

No recent analyst target price found for Cresco Labs Inc
No recent average analyst rating found for Cresco Labs Inc

Company Overview Cresco Labs Inc

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, f...Read More

N/A

N/A

2,760

N/A

CAD

Canada

Adjusted Closing Price for Cresco Labs Inc (CL:CA)

Loading...

Unadjusted Closing Price for Cresco Labs Inc (CL:CA)

Loading...

Share Trading Volume for Cresco Labs Inc Shares

Loading...

Compare Performance of Cresco Labs Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for CL:CA

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Cresco Labs Inc (Sector: Drug Manufacturers - Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
GTII:CA
Green Thumb Industries Inc -0.27 (-1.34%) CAD4.77B 100.55 16.42

ETFs Containing CL:CA

Symbol Name CL:CA's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Cresco Labs Inc (CL:CA) Stock

Based on ratings from 3 analysts Cresco Labs Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 2 buy, sell and 1 hold ratings.

Unfortunately we do not have enough data on CL:CA's stock to indicate if its a good dividend stock.

Based on targets from 3 analysts, the average taret price for CL:CA is CAD 2.98 over the next 12 months. The maximum analyst target price is CAD 3.75 while the minimum anlayst target price is CAD 2.5.

Unfortunately we do not have enough data on CL:CA's stock to indicate if its overvalued.

The last closing price of CL:CA's stock was CAD 2.78.

The most recent market capitalization for CL:CA is CAD 0.94B.

Based on targets from 3 analysts, the average taret price for CL:CA is projected at CAD 2.98 over the next 12 months. This means that CL:CA's stock price may go up by +7.31% over the next 12 months.

We can't find any ETFs which contains Cresco Labs Inc's stock.

As per our most recent records Cresco Labs Inc has 2,760 Employees.

Sorry we do not have any infomation available on Cresco Labs Inc's address.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...